{
  "id": 14235302,
  "title": "Targeted radioactive therapy may help delay spread of recurrent prostate cancer",
  "url": "https://urgent.news/2026/10/13/targeted-radioactive-therapy-may-help-delay-spread-of-recurrent",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T15:40:31.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-radioactive-therapy-delay-recurrent-prostate.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}